(Public interest incorporated foundation) Tokyo Metropolitan Small and Medium Enterprise Promotion Corporation "2013 collaborative innovation promotion program subsidy project"
The development of a new external preparation using paramylon, a unique ingredient of Euglena, was adopted.

Euglena Co., Ltd.

　Euglena Co., Ltd. (Headquarters: Bunkyo-ku, Tokyo, President: Mitsuru Izumo) has adopted the "2013 Collaborative Innovation Promotion Program Grant Project" by the Tokyo Metropolitan Small and Medium Enterprise Promotion Corporation, which is unique to Euglena. We would like to report that we received this in "Development of a new external preparation to prevent and improve euglena (reading: jokuso) (bed slippage)" using the ingredient paramylon.
　We have filed a patent application (May 2, 2012) for a wound healing promoting effect in a paramylon film made using paramylon, which is a component peculiar to Euglena (scientific name: Euglena). In this adoption, we will take advantage of this effect and work on the development of new external preparations that are effective in preventing and improving pressure ulcers.
　In addition, pressure ulcer means that the tissue becomes necrotic due to the skin being pressed for a long time, and its prevention includes the use of bedding with nutritional management and body pressure distribution function. As the aging of society is expected in the future, the demand for prevention and improvement of pressure ulcers is expected to increase. Therefore, we will contribute to the nutritional management of many people through the spread of foods containing euglena. We aim to contribute to an aging society by developing new products that help prevent and improve pressure ulcers using this subsidy program.
　The details are as follows.

About adoption of "2013 cooperation innovation promotion program subsidy project"

■ Name of the subsidized project that was adopted
　Tokyo Metropolitan Small and Medium Enterprise Promotion Corporation "2013 Collaborative Innovation Promotion Program Grant Program"
■ R & D theme
　Development of a new topical agent to prevent and improve pressure ulcers using paramylon, a unique ingredient of Euglena
■ Program overview
　Create a film using Paramylon, a unique ingredient of Euglena (scientific name: Euglena). Focusing on the efficacy of "paramylon", which has the effect of enhancing healing power, we will verify the preventive / ameliorating effect of pressure ulcers.
■ Program period
　January 2014-December 2015 (2 years)
■ Grant amount (planned)
　19,704,000 yen (2/3 of the total)

About Euglena Co., Ltd.
Head Office / Research Institute: 7-3-1 Hongo, Bunkyo-ku, Tokyo University Entrepreneur Plaza 7th floor
Sales: 2,091 million yen (consolidated, FY09 / 13)
Number of employees: 75 (consolidated, as of October 31, 2013)
Business: In 2005, we succeeded in developing the world's first outdoor mass culture technology for Euglena (scientific name: Euglena), which is a microalgae. Using the Euglena, we develop and sell functional foods, cosmetics, etc., and conduct research for water purification and biofuel production. Listed on TSE Mothers in December 2012.

◇ Glossary
Euglena: A type of algae (Japanese name: Euglena), which has 59 kinds of abundant nutrients such as vitamins, essential amino acids, and DHA, as well as growing by photosynthesis while absorbing carbon dioxide and bio. Since it is a raw material for fuel, it is attracting attention as a material that helps solve food and environmental problems.
Paramylon: A component unique to Euglena, a polysaccharide in which glucose molecules are linearly polymerized by β-1,3-bonds. Euglena stores the energy acquired by itself as a stored polysaccharide in the cell.

​ ​

-Contact for inquiries from the press-
Euglena Co., Ltd. Public Relations and IR Division